Molecular mechanism of nucleotide-induced primary granule release in human neutrophils: Role for the P2Y2 receptor

American Journal of Physiology - Cell Physiology

Volumn 286, Issue 2 55-2, 2004, Pages

  Meshki, John ^a   Tuluc, Florin ^a   Bredetean, Ovidiu ^a   Ding, Zhongren ^a   Kunapuli, Satya P ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine triphosphate; Elastase release; Extracellular nucleotides; Fibrinogen; Uridine triphosphate

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CALCIUM; ELASTASE; FIBRINOGEN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; NUCLEOTIDE; PERTUSSIS TOXIN; PURINE P2Y2 RECEPTOR; SYNAPTOPHYSIN; URIDINE TRIPHOSPHATE;

ARTICLE; CALCIUM CELL LEVEL; CELL GRANULE; CONTROLLED STUDY; DEGRANULATION; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; HUMAN CELL; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0742323132     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00287.2003     Document Type: Article

References (57)

1. Altieri DC, Wiltse WL, and Edgington TS. Signal transduction initiated by extracellular nucleotides regulates the high affinity ligand recognition of the adhesive receptor CD11b/CD18. J Immunol 145: 662-670, 1990.
2. Axtell RA, Sandborg RR, Smolen JE, Ward PA, and Boxer LA. Exposure of human neutrophils to exogenous nucleotides causes elevation in intracellular calcium, transmembrane calcium fluxes, and an alteration of a cytosolic factor resulting in enhanced superoxide production in response to FMLP and arachidonic acid. Blood 75: 1324-1332, 1990.
3. Balazovich KJ and Boxer LA. Extracellular adenosine nucleotides stimulate protein kinase C activity and human neutrophil activation. J Immunol 144: 631-637, 1990.
4. 2+ in human erythroleukemia cells. J Biol Chem 272: 10151-10159, 1997.
5. Bini A, Fenoglio JJ Jr, Mesa-Tejada R, Kudryk B, and Kaplan KL. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. Arteriosclerosis 9: 109-121, 1989.
6. Blackwell GJ and Flower RJ. 1-phenyl-3-pyrazolidone: an inhibitor of cyclo-oxygenase and lipoxygenase pathways in lung and platelets. Prostaglandins 16: 417-425, 1978.
7. Boarder MR, Weisman GA, Turner JT, and Wilkinson GF. G protein-coupled P2 purinoceptors: from molecular biology to functional responses. Trends Pharmacol Sci 16: 133-139, 1995.
8. Borregaard N. The human neutrophil. Function and dysfunction. Eur J Haematol 41: 401-413, 1988.
9. Clifford EE, Martin KA, Dalal P, Thomas R, and Dubyak GR. Stage-specific expression of P2Y receptors, ecto-apyrase, and ecto-5′-nucleotidase in myeloid leukocytes. Am J Physiol Cell Physiol 273: C973-C987, 1997.
10. Cobb MH and Goldsmith EJ. How MAP kinases are regulated. J Biol Chem 270: 14843-14846, 1995.
11. Cockcroft S, and Stutchfield J. ATP stimulates secretion in human neutrophils and HL60 cells via a pertussis toxin-sensitive guanine nucleotide-binding protein coupled to phospholipase C. FEBS Lett 245: 25-29, 1989.
12. Cockcroft S, and Stutchfield J. The receptors for ATP and fMetLeuPhe are independently coupled to phospholipases C and A2 via G-protein(s). Relationship between phospholipase C and A2 activation and exocytosis in HL60 cells and human neutrophils. Biochem J 263: 715-723, 1989.
13. Communi D, Govaerts C, Parmentier M, and Boeynaems JM. Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J Biol Chem 272: 31969-31973, 1997.
14. Cowen DS, Berger M, Nuttle L, and Dubyak GR. Chronic treatment with P2-purinergic receptor agonists induces phenotypic modulation of the HL-60 and U937 human myelogenous leukemia cell lines. J Leukoc Biol 50: 109-122, 1991.
15. Cowen DS, Lazarus HM, Shurin SB, Stoll SE, and Dubyak GR. Extracellular adenosine triphosphate activates calcium mobilization in human phagocytic leukocytes and neutrophil/monocyte progenitor cells. J Clin Invest 83: 1651-1660, 1989.
16. Downey GP, Butler JR, Tapper H, Fialkow L, Saltiel AR, Rubin BB, and Grinstein S. Importance of MEK in neutrophil microbicidal responsiveness. J Immunol 160: 434-443, 1998.
17. Dubyak GR. Knock-out mice reveal tissue-specific roles of P2Y receptor subtypes in different epithelia. Mol Pharmacol 63: 773-776, 2003.
18. Dubyak GR and Cowen DS. Activation of inositol phospholipid-specific phospholipase C by P2-purinergic receptors in human phagocytic leukocytes. Role of pertussis toxin-sensitive G proteins. Ann NY Acad Sci 603: 227-244; discussion 244-245, 1990.
19. o-mediated signal transduction. J Cell Biol 153: 491-501, 2001.
20. Erb L, Lustig KD, Sullivan DM, Turner JT, and Weisman GA. Functional expression and photoaffinity labeling of a cloned P2U purinergic receptor. Proc Natl Acad Sci USA 90: 10449-10453, 1993.
21. Flezar M, Olivenstein R, Cantin A, and Heisler S. Extracellular ATP stimulates elastase secretion from human neutrophils and increases lung resistance and secretion from normal rat airways after intratracheal instillation. Can J Physiol Pharmacol 70: 1065-1068, 1992.
22. Gillard J, Ford-Hutchinson AW, Chan C, Charleson S, Denis D, Foster A, Fortin R, Leger S, McFarlane CS, Morton H, Piechuta H, Reindeau D, Rouzer CA, Rokach J, Young R, MacIntyre DE, Peterson L, Bach T, Eiermann G, Hopple S, Humes J, Hupe L, Luell S, Metzger J, Meurer R, Miller DK, Opas E, and Pacholok S. L-663,536 (MK-886) {3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2, 2-dimethylpropanoic acid}, a novel, orally active leukotriene biosynthesis inhibitor. Can J Physiol Pharmacol 67: 456-464, 1989.
23. Gordon JL. Extracellular ATP: effects, sources and fate. Biochem J 233: 309-319, 1986.
24. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985.
25. 2 receptor (-/-) mice. J Biol Chem 274: 26454-26460, 1999.
26. Ingerman CM, Smith JB, and Silver MJ. Direct measurement of platelet secretion in whole blood. Thromb Res 16: 335-344, 1979.
27. Jin J, Dasari VR, Sistare FD, and Kunapuli SP. Distribution of P2Y receptor subtypes on haematopoietic cells. Br J Pharmacol 123: 789-794, 1998.
28. 3 and ADP receptors. Blood 99: 193-198, 2002.
29. 4. J Immunol 167: 2869-2878, 2001.
30. - generation. Lab Invest 58: 448-453, 1988.
31. Lazarowski ER, Watt WC, Stutts MJ, Boucher RC, and Harden TK. Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate. Br J Pharmacol 116: 1619-1627, 1995.
32. Lu H, Smith CW, Perrard J, Bullard D, Tang L, Shappell SB, Entman ML, Beaudet AL, and Ballantyne CM. LFA-1 is sufficient in mediating neutrophil emigration in Mac-l-deficient mice. J Clin Invest 99: 1340-1350, 1997.
33. Martin KA, Kertesy SB, and Dubyak GR. Down-regulation of P2U-purinergic nucleotide receptor messenger RNA expression during in vitro differentiation of human myeloid leukocytes by phorbol esters or inflammatory activators. Mol Pharmacol 51: 97-108, 1997.
34. McRitchie DI, Girotti MJ, Glynn MF, Goldberg JM, and Rotstein OD. Effect of systemic fibrinogen depletion on intra-abdominal abscess formation. J Lab Clin Med 118: 48-55, 1991.
35. Mills DC. ADP receptors on platelets. Thromb Haemost 76: 835-856, 1996.
36. Mocsai A, Jakus Z, Vantus T, Berton G, Lowell CA, and Ligeti E. Kinase pathways in chemoattractant-induced degranulation of neutrophils: the role of p38 mitogen-activated protein kinase activated by Src family kinases. J Immunol 164: 4321-4331, 2000.
37. Nicholas RA, Lazarowski ER, Watt WC, Li Q, Boyer J, and Harden TK. Pharmacological and second messenger signalling selectivities of cloned P2Y receptors. J Auton Pharmacol 16: 319-323, 1996.
38. Nicholas RA, Watt WC, Lazarowski ER, Li Q, and Harden K. Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor. Mol Pharmacol 50: 224-229, 1996.
39. Okajima F, Tokumitsu Y, Kondo Y, and Ui M. P2-purinergic receptors are coupled to two signal transduction systems leading to inhibition of cAMP generation and to production of inositol trisphosphate in rat hepatocytes, J Biol Chem 262: 13483-13490, 1987.
40. Parr CE, Sullivan DM, Paradiso AM, Lazarowski ER, Burch LH, Olsen JC, Erb L, Weisman GA, Boucher RC, and Turner JT. Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc Natl Acad Sci USA 91: 13067, 1994.
41. Pearson JD and Gordon JL. Vascular endothelial and smooth muscle cells in culture selectively release adenine nucleotides. Nature 281: 384-386, 1979.
42. Pillinger MH, Feoktistov AS, Capodici C, Solitar B, Levy J, Oei TT, and Philips MR. Mitogen-activated protein kinase in neutrophils and enucleate neutrophil cytoplasts: evidence for regulation of cell-cell adhesion. J Biol Chem 271: 12049-12056, 1996.
43. Rainger GE, Rowley AF, and Nash GB. Adhesion-dependent release of elastase from human neutrophils in a novel, flow-based model: specificity of different chemotactic agents. Blood 92: 4819-4827, 1998.
44. Ralevic V and Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 50: 413-492, 1998.
45. Rubel C, Fernandez GC, Dran G, Bompadre MB, Isturiz MA, and Palermo MS. Fibrinogen promotes neutrophil activation and delays apoptosis. J Immunol 166: 2002-2010, 2001.
46. Rubel C, Fernandez GC, Rosa FA, Gomez S, Bompadre MB, Coso OA, Isturiz MA, and Palermo MS. Soluble fibrinogen modulates neutrophil functionality through the activation of an extracellular signal-regulated kinase-dependent pathway. J Immunol 168: 3527-3535, 2002.
47. Seifert R, Burde R, and Schultz G. Activation of NADPH oxidase by purine and pyrimidine nucleotides involves G proteins and is potentiated by chemotactic peptides. Biochem J 259: 813-819, 1989.
48. Seifert R, Wenzel K, Eckstein F, and Schultz G. Purine and pyrimidine nucleotides potentiate activation of NADPH oxidase and degranulation by chemotactic peptides and induce aggregation of human neutrophils via G proteins. Eur J Biochem 181: 277-285, 1989.
49. Soltoff SP, Avraham H, Avraham S, and Cantley LC. Activation of P2Y2 receptors by UTP and ATP stimulates mitogen-activated kinase activity through a pathway that involves related adhesion focal tyrosine kinase and protein kinase C. J Biol Chem 273: 2653-2660, 1998.
50. Van der Weyden L, Conigrave AD, and Morris MB. Signal transduction and white cell maturation via extracellular ATP and the P2Y11 receptor. Immunol Cell Biol 78: 369-374, 2000.
51. Verghese MW, Charles L, Jakoi L, Dillon SB, and Snyderman R. Role of a guanine nucleotide regulatory protein in the activation of phospholipase C by different chemoattractants. J Immunol 138: 4374-4380, 1987.
52. Verghese MW, Kneisler TB, and Boucheron JA. P2U agonists induce chemotaxis and actin polymerization in human neutrophils and differentiated HL60 cells. J Biol Chem 271: 15597-15601, 1996.
53. Walker BA, Hagenlocker BE, Douglas VK, Tarapchak SJ, and Ward PA. Nucleotide responses of human neutrophils. Lab Invest 64: 105-112, 1991.
54. -. responses of human neutrophils. Biochem Biophys Res Commun 154: 746-751, 1988.
55. Wu X, Helfrich MH, Horton MA, Feigen LP, and Lefkowith JB. Fibrinogen mediates platelet-polymorphonuclear leukocyte cooperation during immune-complex glomerulonephritis in rats. J Clin Invest 94: 928-936, 1994.
56. Xie MS and Dubyak GR. Guanine-nucleotide- and adenine-nucleotide-dependent regulation of phospholipase D in electropermeabilized HL-60 granulocytes. Biochem J 278: 81-89, 1991.
57. Zhang Y, Palmblad J, and Fredholm BB. Biphasic effect of ATP on neutrophil functions mediated by P2U and adenosine A2A receptors. Biochem Pharmacol 51: 957-965, 1996.